PhRMA Spent $6.2M Lobbying In 2Q
WASHINGTON - The pharmaceutical industry's primary trade group spent nearly $6.2 million lobbying in the second quarter on health care reform provisions, confirmation of two top federal officials and other issues, according to a recent disclosure report.
The Pharmaceutical Research and Manufacturers of America spent about $5 million on lobbying in the year-ago period. The group's members include drug giants Pfizer Inc., Merck & Co., Johnson & Johnson and more than two dozen other U.S. and foreign companies.



First Posted: 09/20/09 06:12 AM ET Updated: 05/25/11 02:55 PM ET